• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CNS border posts against rituximab?

作者信息

Kasenda Benjamin, Illerhaus Gerald

机构信息

Department of Haematology/Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart Cancer Centre, 70174 Stuttgart, Germany; Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.

Department of Haematology/Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart Cancer Centre, 70174 Stuttgart, Germany.

出版信息

Lancet Oncol. 2019 Feb;20(2):169-170. doi: 10.1016/S1470-2045(18)30829-5. Epub 2019 Jan 7.

DOI:10.1016/S1470-2045(18)30829-5
PMID:30630773
Abstract
摘要

相似文献

1
CNS border posts against rituximab?中枢神经系统对利妥昔单抗的边界防御？
Lancet Oncol. 2019 Feb;20(2):169-170. doi: 10.1016/S1470-2045(18)30829-5. Epub 2019 Jan 7.
2
Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab.采用抗CD20抗体利妥昔单抗对复发性中枢神经系统淋巴瘤进行脑室内治疗。
Haematologica. 2004 Jun;89(6):753-4.
3
Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study.鞘内注射利妥昔单抗、大剂量甲氨蝶呤以及R-DHAP方案序贯自体干细胞移植治疗继发性中枢神经系统淋巴瘤：HOVON 80二期研究结果
Hematol Oncol. 2017 Dec;35(4):497-503. doi: 10.1002/hon.2342. Epub 2016 Aug 17.
4
Immunochemotherapy, the New Standard of Care for Primary CNS Lymphoma: However, Which One?
J Clin Oncol. 2016 Nov 20;34(33):4056-4057. doi: 10.1200/JCO.2016.68.9018. Epub 2016 Oct 31.
5
Salvage immuno-chemotherapy with a combination of rituximab, high-dose cytarabine, mitoxantrone and dexamethasone for patients with primary CNS lymphoma: a preliminary study.
Leuk Lymphoma. 2007 Jul;48(7):1429-33. doi: 10.1080/10428190701370605.
6
Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.利妥昔单抗脑室内给药治疗复发性中枢神经系统和眼内淋巴瘤的I期研究。
J Clin Oncol. 2007 Apr 10;25(11):1350-6. doi: 10.1200/JCO.2006.09.7311. Epub 2007 Feb 20.
7
[Outcomes of primary central nervous system lymphoma patients treated with high-dose methotrexate and rituximab].[接受大剂量甲氨蝶呤和利妥昔单抗治疗的原发性中枢神经系统淋巴瘤患者的治疗结果]
Rinsho Ketsueki. 2019;60(2):87-92. doi: 10.11406/rinketsu.60.87.
8
Intraventricular treatment of secondary central nervous system lymphoma - Case study and literature overview.中枢神经系统继发性淋巴瘤的脑室内治疗——病例研究与文献综述
Neurol Neurochir Pol. 2018 May-Jun;52(3):410-414. doi: 10.1016/j.pjnns.2018.01.007. Epub 2018 Feb 6.
9
Rituximab with high-dose methotrexate in primary central nervous system lymphoma.利妥昔单抗联合大剂量甲氨蝶呤治疗原发性中枢神经系统淋巴瘤。
Am J Hematol. 2015 Dec;90(12):1149-54. doi: 10.1002/ajh.24204. Epub 2015 Nov 17.
10
Current management of primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤的当前管理
Chin Clin Oncol. 2017 Aug;6(4):38. doi: 10.21037/cco.2017.06.24.

引用本文的文献

1
Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China.非清髓性化疗作为原发性中枢神经系统淋巴瘤患者基于大剂量甲氨蝶呤的化疗免疫治疗后的巩固策略：一项中国单中心回顾性研究
Front Oncol. 2022 Feb 23;12:792274. doi: 10.3389/fonc.2022.792274. eCollection 2022.
2
An Iatrogenic Model of Brain Small-Vessel Disease: Post-Radiation Encephalopathy.医源性脑小血管病模型：放射性脑病。
Int J Mol Sci. 2020 Sep 5;21(18):6506. doi: 10.3390/ijms21186506.